TLSI
TriSalus Life Sciences Inc.
NASDAQ: TLSI · HEALTHCARE · MEDICAL DEVICES
$4.39
+1.62% today
Updated 2026-05-01
Market cap
$275.75M
P/E ratio
—
P/S ratio
6.11x
EPS (TTM)
$-1.84
Dividend yield
—
52W range
$3 – $8
Volume
0.2M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.0
Profitability
F4.0
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
$9.20
+109.57%
12-Month target
—
—
Intrinsic (DCF)
$3.15
Margin of safety
-51.43%
1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 59.80% QoQ
Risks
- Thin margins at -86.90%
- Negative free cash flow $-2.52M
- 51.43% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $12.40M | $18.51M | $29.43M | $45.15M | $45.15M |
| Net income | $-47.19M | $-59.36M | $-33.23M | $-39.23M | $-9.75M |
| EPS | — | — | — | — | $-1.84 |
| Free cash flow | $-33.10M | $-51.17M | $-41.19M | $-18.93M | $-2.52M |
| Profit margin | -380.60% | -320.69% | -112.92% | -86.88% | -86.90% |
Peer comparison
Smart narrative
TriSalus Life Sciences Inc. trades at $4.39. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $45.15M. with profit margins at -86.90%. Our DCF model estimates intrinsic value at $3.15.
Frequently asked questions
What is TriSalus Life Sciences Inc.'s stock price?
TriSalus Life Sciences Inc. (TLSI) trades at $4.39.
Is TriSalus Life Sciences Inc. overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $3.15.
What is the price target of TriSalus Life Sciences Inc. (TLSI)?
The analyst target price is $9.20, representing +109.6% upside from the current price of $4.39.
What is the intrinsic value of TriSalus Life Sciences Inc. (TLSI)?
Based on our DCF model, intrinsic value is $3.15, a -51.4% margin of safety versus $4.39.
What is TriSalus Life Sciences Inc.'s revenue?
TTM revenue is $45.15M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.11x
ROE-496.20%
Beta0.54
50D MA$4.43
200D MA$5.00
Shares out0.06B
Float0.05B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—